#ASGCT21 is available on demand until August 13!
Access the Meeting Platform

FDA/Center for Biologics Evaluation and Research

Silver Spring,  MD 
United States

Hello ASGCT, join us and explore the opportunities at FDA!

The Center for Biologics Evaluation & Research (CBER) within the Food & Drug Administration (FDA) regulates biological products for human use under applicable federal laws. CBER's Office of Tissues and Advanced Therapies plans and conducts research related to the development, manufacture, and testing of cellular, tissue, and gene therapy products.